Mirae Asset Global Investments’s Silence Therapeutics SLN Stock Holding History

Mirae Asset Global Investments’s Portfolio SLN Stock Details SLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.1K	Sell	2,101 -349	-14%	-$2.46K	﹤0.01%	1471
2026 Q1	$12.9K	Buy	2,450 +168	+7%	+$925	﹤0.01%	1477
2025 Q4	$13.9K	Buy	2,282 +466	+26%	+$2.98K	﹤0.01%	1583
2025 Q3	$9.43K	Sell	1,816 -1	-0.1%	-$6	﹤0.01%	1582
2025 Q2	$10.5K	Buy	1,817 +244	+16%	+$1.05K	﹤0.01%	1483
2025 Q1	$5.41K	Buy	1,573 +7	+0.4%	+$34	﹤0.01%	1511
2024 Q4	$11.1K	Buy	+1,566	New	+$20.2K	﹤0.01%	1502

Other funds holding SLN

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Mirae Asset Global Investments's SLN Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Silence Therapeutics (SLN) stake by 14% in Q2 2026, selling an estimated $2.46K and leaving 2,101 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1471.

Mirae Asset Global Investments first reported a position in SLN in Q4 2024 and has held it in 7 quarters since. 4 funds tracked by Wall St. Rank hold SLN as of Q2 2026.

Mirae Asset Global Investments held 2,101 shares of Silence Therapeutics worth $23.1K as of Q2 2026.
Mirae Asset Global Investments sold 349 Silence Therapeutics shares in Q2 2026, an estimated $2.46K.
Silence Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1471 holding.
Mirae Asset Global Investments first reported a position in Silence Therapeutics in Q4 2024 and has held it in 7 quarters since.
4 funds tracked by Wall St. Rank held Silence Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.